Kirin says that functional drinks from its health science domain are the “particular focus” for its beverage business this year after sales of its LC-Plasma immunity range increased by 8.5 per cent to 1.71 million cases in Q1.
Japanese firm Kirin is expanding its presence in South East Asia with its flagship postbiotic ingredient, with collaborations with major dairy companies underway.
Kirin is aiming a 20 per cent growth in the number of regular consumers buying functional foods and drinks containing its immune health ingredient LC-plasma – and it is seeking to do so by working with brands that can incorporate the ingredient into various...
